RAND

Rand is a tiny, externally-managed BDC (only 2.97M shares, ~$52.2M of equity) that invests in debt and equity of small, non-public companies. The headline FY2025 net loss of $8.04M (EPS -$2.73, ROE -15.4%) is not an operating cash burn — operating cash flow was actually +$11.3M — but rather unrealized/realized markdowns on the illiquid portfolio, which is exactly the risk the MD&A flags ('the valuation of our portfolio investments,' small covenant-lite loans to non-traded companies). The clearest valuation fact is the discount to net asset value: stockholders' equity of $52.2M over 2.97M shares is ~$17.58 of NAV per share, so at $10.32 the stock trades near 0.59x book — a ~41% discount the filing itself acknowledges ('our shares often trading at a discount to our net asset value'). That discount, plus a nearly debt-free balance sheet (liabilities/equity 0.02x) and a rising cash pile ($4.21M, +404%), is the value/income case.

What holds it back from a buy is that the NAV backing the discount is eroding: total assets fell 26.6%, equity fell 20.1%, and the accumulated deficit worsened to -$10.6M. A discount to a shrinking, marked-down book is far less compelling than a discount to a growing one. Net income has also been wildly volatile ($15.8M → -$0.9M → $6.5M → $8.8M → -$8.0M), reflecting a concentrated portfolio where a few positions swing results — the 10-K stresses 'the limited number of companies in our portfolio' and 'heightened risk if any of those companies perform poorly.'